Sudan He Selected Research

Sudan He Research Topics

Disease

13	Necrosis 01/2022 - 06/2009
10	Neoplasms (Cancer) 11/2020 - 03/2015
8	Infections 12/2023 - 10/2014
4	Neoplasm Metastasis (Metastasis) 11/2020 - 01/2019
3	Autoimmune Diseases (Autoimmune Disease) 10/2023 - 11/2020
3	Inflammation (Inflammations) 11/2020 - 01/2017
2	Virus Diseases (Viral Diseases) 10/2022 - 01/2020
2	HIV Infections (HIV Infection) 11/2020 - 01/2020
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 07/2018
2	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2019 - 01/2017
2	Thrombosis (Thrombus) 01/2017 - 01/2014
1	Leukemia 01/2023
1	Peritonitis 01/2023
1	Colitis 01/2023
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2022
1	Rhabdomyosarcoma 10/2022
1	Human Influenza (Influenza) 01/2022
1	Pathologic Processes 01/2022
1	Lung Injury 01/2022
1	Carcinogenesis 01/2021
1	Bites and Stings (Sting) 01/2021
1	Cardiotoxicity 01/2020
1	Carcinoma (Carcinomatosis) 01/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 07/2018
1	Deafness (Deaf Mutism) 08/2014
1	Carotid Artery Injuries 01/2014
1	Neuroinflammatory Diseases 01/2014
1	Hemorrhage 01/2014
1	Hearing Loss (Hearing Impairment) 07/2011
1	Nonsyndromic Deafness 07/2011

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 12/2023 - 07/2011
9	Phosphotransferases (Kinase)IBA 01/2022 - 06/2009
3	CytokinesIBA 01/2023 - 06/2009
3	Antiviral Agents (Antivirals)IBA 01/2022 - 10/2014
3	CaspasesIBA 02/2020 - 01/2014
3	Protein Kinases (Protein Kinase)IBA 01/2020 - 01/2016
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016 - 06/2009
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2023 - 12/2011
2	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2020
2	Serine (L-Serine)FDA Link 01/2021 - 01/2012
2	Chemokine ReceptorsIBA 11/2020 - 01/2020
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020 - 12/2011
2	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 01/2016 - 10/2014
1	Interleukin-1 Receptor-Associated KinasesIBA 10/2023
1	Acetylmuramyl-Alanyl-IsoglutamineIBA 01/2023
1	Histocompatibility Antigens Class IIIBA 01/2023
1	2,4-dinitrofluorobenzene sulfonic acidIBA 01/2023
1	ChemokinesIBA 01/2023
1	ProteomeIBA 10/2022
1	InterferonsIBA 01/2021
1	pyrrolidineIBA 11/2020
1	Receptor-Interacting Protein Serine-Threonine KinasesIBA 02/2020
1	LigandsIBA 01/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020
1	Caspase 8 (Caspase-8)IBA 01/2020
1	Death Domain ReceptorsIBA 01/2020
1	metapristoneIBA 01/2019
1	N- (6- (2- bromoacetyl)benzo(d)thiazol- 2- yl)acetamideIBA 01/2019
1	HhAntag691IBA 07/2018
1	Sp1 Transcription FactorIBA 10/2017
1	UbiquitinIBA 10/2017
1	Transcription Factors (Transcription Factor)IBA 10/2017
1	PHA 767491IBA 01/2017
1	EndotoxinsIBA 03/2015
1	ainsliadimer AIBA 03/2015
1	SilverIBA 08/2014
1	SiliconIBA 08/2014
1	DNA (Deoxyribonucleic Acid)IBA 08/2014
1	ferric chlorideIBA 01/2014
1	8- ethoxy- 2- (4- fluorophenyl)- 3- nitro- 2H- chromeneIBA 01/2014
1	Threonine (L-Threonine)FDA Link 01/2012
1	Serine-Threonine Kinase 3IBA 01/2012
1	N- (4- (N- (3- methoxypyrazin- 2- yl)sulfamoyl)phenyl)- 3- (5- nitrothiophene- 2- yl)acrylamideIBA 01/2012
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2011
1	Poly I-CIBA 12/2011
1	Caspase InhibitorsIBA 06/2009
1	Small Interfering RNA (siRNA)IBA 06/2009

Therapy/Procedure

3	Therapeutics 01/2020 - 04/2018
1	Quantum Dots (Quantum Dot) 11/2016